Daily non-political popular news in brief.
Leukemia drug proves safe and effective over the long term
11-07-2007 · EurekAlert!The drug imatinib mesylate, more commonly known as Gleevec, proves safe and effective over the long term in patients with an advanced form of chronic myeloid leukemia, according to a study prepublished online in Blood, the official journal of the American Society of Hematology.
Read more »
Keywords: leukemia, drug, proves, safe, effective, term, prove
« Previous | Next »
Similar news on "Leukemia drug proves safe and effective over the long term":
- Early Phase II results show bosutinib safe, effective for CML
12-11-2007 · EurekAlert!
A new drug for chronic myelogenous leukemia works for patients who have developed resistance to frontline therapy and causes fewer side effects than other medications in its class, a research team led by scientists at the University of Texas M. D. Anderson Cancer Center reports at the 49th annual meeting of the American Society of Hematology.
Similar news · Read more »
- Clinical trials nebulized formoterol fumarate: Long-term and cardiovascular safety COPD
10-24-2007 · EurekAlert!
Data from two Phase III clinical trials were presented today in Chicago at CHEST 2007, the annual scientific assembly of the American College of Chest Physicians, supporting the use of Perforomist Inhalation Solution as a safe and effective maintenance treatment for COPD patients.
Similar news · Read more »
- Minimally invasive device shows promise in treating female urinary incontinence
05-22-2007 · EurekAlert!
A minimally invasive device for treating recurrent stress urinary incontinence in women has been shown to be safe and effective in early clinical trials and is now under review by the US Food and Drug Administration (FDA), says Emory University School of Medicine urologist and trial co-principal investigator Niall Galloway, MD.
Similar news · Read more »
- Studies led by Rhode Island Hospital confirm safety and efficacy
11-17-2006 · EurekAlert!
Following two studies of patients who were treated with cardiac stents, physicians at Rhode Island Hospital continue to recommend drug-eluting stents as a safe and effective treatment.
Similar news · Read more »
- Anti-anginal drug safe but not effective in reducing major cardiac events in ACS patients
04-24-2007 · EurekAlert!
The anti-anginal medication ranolazine was shown to be safe in regard to certain outcomes but did not reduce the risk of major cardiovascular events such as death, heart attack or recurrent ischemia following acute coronary syndromes, according to a study in the April 25 issue of JAMA.
Similar news · Read more »
- Drug-eluting stents yield better outcomes than bare-metal ones
11-19-2007 · EurekAlert!
Rhode Island Hospital researchers report that drug-eluting stents are just as safe and effective as traditonal bare-metal stents when used in routine clinical practice.
Similar news · Read more »
- New drug candidate knocks out resistant form of chronic myeloid leukemia
12-10-2007 · EurekAlert!
Oregon Health & Science University Cancer Institute researchers have found a new, experimental drug candidate it to be effective against a highly resistant mutation in chronic myeloid leukemia.
Similar news · Read more »
- Popular ADHD drug safe and effective for pre-schoolers
10-23-2006 · EurekAlert!
A new study by researchers from the Johns Hopkins Children's Center and five other medical centers concludes that carefully measured, low doses of methylphenidate (Ritalin) are safe and effective for attention-deficit and hyperactivity disorder (ADHD) in preschoolers. Investigators warn, however, that three to five-year-olds appear more sensitive to the drug's side effects, which include irritability, insomnia and weight loss, than are older children with ADHD and require closer monitoring.
Similar news · Read more »
- Good news for rural stroke patients -- telephone treatment works
04-24-2007 · EurekAlert!
Stroke patients in rural hospitals can get safe, effective treatment with the use of a clot-busting drug when a doctor from a larger hospital is on the telephone guiding the treatment. These new findings have important implications for overcoming barriers to optimal stroke care in rural settings, according to research to be presented at the American Academy of Neurology's 59th Annual Meeting in Boston, April 28-May 5, 2007.
Similar news · Read more »
- New strategy to cut heart attack risk is effective in initial test
12-17-2007 · EurekAlert!
The first clinical trial of a new kind of drug to cut the risk of cardiovascular disease has been found safe and effective at dropping levels of "bad" low density lipoprotein cholesterol by as much as 40 percent. High LDL levels increase the risk for heart attack and stroke.
Similar news · Read more »